Trupanion Inc (TRUP)
Official siteFINANCIAL SERVICES • INSURANCE - PROPERTY & CASUALTY • NASDAQ
Market Cap: $1.49B
Last updated: Nov 17, 2026 at 4:33 PM ET
Trupanion Inc (TRUP) Stock Chart
Trupanion (TRUP) has a latest price of $36.55 on Nov 17, 2026, 6.0% below its 52-week high of $38.87. Its price fell 3.2% over the past 12 months. The month-end price rose 86.1% over the 10 years through Oct 2026, a compound annual rate of 6.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $132.03 in Dec 2021 and its lowest $14.22 in Mar 2017, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TRUP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TRUP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 17.5%, and over 6 months it rose 65.5%. The month-end price rose 46.3% over the 3 years through Oct 2026, a compound annual rate of 13.5%.
| Period | Change |
|---|---|
| 1 month | +32.9% |
| 3 months | +17.5% |
| 6 months | +65.5% |
| 12 months | -3.2% |
| 12 months, with dividends | -3.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +46.3% | +13.5% |
| 5 years | -70.6% | -21.7% |
| 10 years | +86.1% | +6.4% |
Price by Year
Its best calendar year was 2020, when the price rose 219.6%, and its weakest was 2022, when it fell 64.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $30.13 | -19.4% |
| 2025 | $37.37 | -22.5% |
| 2024 | $48.20 | +58.0% |
| 2023 | $30.51 | -35.8% |
| 2022 | $47.53 | -64.0% |
| 2021 | $132.03 | +10.3% |
| 2020 | $119.71 | +219.6% |
| 2019 | $37.46 | +47.1% |
| 2018 | $25.46 | -13.0% |
| 2017 | $29.27 | +88.6% |
Trading Range
The price is 30.1% above its 50-day average of $28.10 and 36.8% above its 200-day average of $26.73.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $36.55 | |
| 52-week high | $38.87 | -6.0% |
| 52-week low | $21.16 | +72.7% |
| 50-day average | $28.10 | +30.1% |
| 200-day average | $26.73 | +36.8% |
Price Risk
Over 3 years, its largest fall from a peak was 62.0%.
| Measure | Value |
|---|---|
| 1-year beta | -0.08 |
| Largest fall, 1 year | -44.2% |
| Largest fall, 3 years | -62.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TRUP
What is TRUP's 1-year price change?
Trupanion's price fell 3.2% over the past 12 months. With dividends included, the 12-month total return was -3.2%.
What is TRUP's 5-year price change?
Trupanion's month-end price fell 70.6% over the 5 years through Oct 2026, a compound annual decline of 21.7%. These figures leave out dividends.
What is TRUP's 52-week high and low?
Trupanion's 52-week high is $38.87 and its 52-week low is $21.16. Its latest price of $36.55 on Nov 17, 2026 is 6.0% below the high.
What is TRUP's beta?
Trupanion's 1-year beta against the S&P 500 is -0.08, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 44.2%.
Is the TRUP chart free?
Yes. Advanced Charting for TRUP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TRUP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors